Robert Burns

Stock Analyst at HC Wainwright & Co.

(1.27)
# 3,521
Out of 4,893 analysts
475
Total ratings
32.69%
Success rate
-13.14%
Average return
Main Sectors:

Stocks Rated by Robert Burns

Cogent Biosciences
Jul 8, 2025
Maintains: Buy
Price Target: $12$22
Current: $10.85
Upside: +102.76%
Replimune Group
Jul 3, 2025
Reiterates: Buy
Price Target: $22
Current: $10.77
Upside: +104.27%
Zymeworks
Jul 3, 2025
Reiterates: Neutral
Price Target: $13
Current: $13.67
Upside: -4.87%
Telix Pharmaceuticals
Jul 3, 2025
Initiates: Buy
Price Target: $23
Current: $16.10
Upside: +42.86%
Enliven Therapeutics
Jul 2, 2025
Maintains: Buy
Price Target: $40$48
Current: $22.75
Upside: +110.99%
Exelixis
Jun 30, 2025
Maintains: Buy
Price Target: $47$53
Current: $45.17
Upside: +17.33%
BioNTech SE
Jun 25, 2025
Reiterates: Buy
Price Target: $138
Current: $113.92
Upside: +21.14%
Immix Biopharma
Jun 4, 2025
Reiterates: Buy
Price Target: $7
Current: $2.70
Upside: +159.74%
Y-mAbs Therapeutics
May 19, 2025
Maintains: Buy
Price Target: $12$11
Current: $4.53
Upside: +142.83%
Bicara Therapeutics
May 16, 2025
Maintains: Buy
Price Target: $44$41
Current: $9.92
Upside: +313.31%
Reiterates: Buy
Price Target: $12
Current: $2.52
Upside: +376.19%
Maintains: Buy
Price Target: $39$40
Current: $22.00
Upside: +81.82%
Maintains: Buy
Price Target: $73$72
Current: $38.50
Upside: +87.01%
Maintains: Buy
Price Target: $21$22
Current: $11.45
Upside: +92.14%
Maintains: Buy
Price Target: $17$18
Current: $4.16
Upside: +332.69%
Reiterates: Buy
Price Target: $5
Current: $0.91
Upside: +449.75%
Maintains: Buy
Price Target: $9$3
Current: $1.74
Upside: +72.41%
Reiterates: Buy
Price Target: $13
Current: $6.11
Upside: +112.77%
Reiterates: Buy
Price Target: $36
Current: $12.67
Upside: +184.14%
Reiterates: Buy
Price Target: $10
Current: $8.37
Upside: +19.55%
Reiterates: Buy
Price Target: $8
Current: $3.30
Upside: +142.42%
Reiterates: Buy
Price Target: $10
Current: $4.11
Upside: +143.31%
Maintains: Neutral
Price Target: $4$2
Current: $1.58
Upside: +26.58%
Reiterates: Buy
Price Target: $5
Current: $1.27
Upside: +293.70%
Maintains: Buy
Price Target: $9$8
Current: $1.26
Upside: +534.92%
Maintains: Buy
Price Target: $11$12
Current: $2.74
Upside: +337.96%
Maintains: Buy
Price Target: $40$34
Current: $2.55
Upside: +1,233.33%
Maintains: Buy
Price Target: $11$10
Current: $2.31
Upside: +332.90%
Maintains: Buy
Price Target: $10$5
Current: $1.56
Upside: +220.51%
Reiterates: Buy
Price Target: $16
Current: $3.73
Upside: +328.95%
Downgrades: Neutral
Price Target: n/a
Current: $4.60
Upside: -
Reiterates: Neutral
Price Target: n/a
Current: $9.54
Upside: -
Maintains: Neutral
Price Target: $12$11
Current: $1.36
Upside: +708.82%
Maintains: Buy
Price Target: $500$200
Current: $5.70
Upside: +3,408.77%
Maintains: Buy
Price Target: $110$20
Current: $1.00
Upside: +1,904.01%
Downgrades: Neutral
Price Target: n/a
Current: $5.99
Upside: -
Reiterates: Buy
Price Target: $150
Current: $2.29
Upside: +6,450.22%
Reiterates: Buy
Price Target: $22
Current: $1.38
Upside: +1,494.20%
Downgrades: Neutral
Price Target: $115$7
Current: $1.16
Upside: +503.45%
Maintains: Buy
Price Target: $12$11
Current: $2.60
Upside: +323.08%
Maintains: Buy
Price Target: $250$225
Current: $0.06
Upside: +376,784.42%
Assumes: Buy
Price Target: $25
Current: $3.55
Upside: +604.21%
Maintains: Buy
Price Target: $19$13
Current: $2.48
Upside: +424.19%